BRIEF published on 08/05/2024 at 07:05, 2 years 3 months ago Relief Therapeutics obtient jusqu'à 11 millions de dollars grâce aux ventes de redevances Développement Clinique Financement Non Dilutif Approbation De La FDA Thérapeutique De Soulagement Ventes De Redevances
PRESS RELEASE published on 08/05/2024 at 07:00, 2 years 3 months ago Relief Therapeutics Secures up to $11 Million from Royalty Sales Relief Therapeutics secures $11 million from royalty sales for RLF-TD011 clinical development and pipeline advancement. Funding from SWK Holdings Corporation to support rare disease treatment options SWK Holdings Corporation Clinical Development Relief Therapeutics Rare Diseases Royalty Sales
BRIEF published on 06/27/2024 at 12:50, 2 years 4 months ago Relief Therapeutics Holding SA publie les résultats de son assemblée générale annuelle Actionnaires Conseil D'administration États Financiers Résultats De L'AGA Thérapeutique De Soulagement
BRIEF published on 06/27/2024 at 12:50, 2 years 4 months ago Relief Therapeutics Holding SA Reports Results of Annual General Meeting Board Of Directors Shareholders Financial Statements Relief Therapeutics AGM Results
PRESS RELEASE published on 06/27/2024 at 12:45, 2 years 4 months ago RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting RELIEF THERAPEUTICS Holding SA announces the results of its Annual General Meeting of Shareholders in Geneva. Details on approved resolutions and election outcomes Annual General Meeting Shareholders Resolutions RELIEF THERAPEUTICS Holding SA Geneva
BRIEF published on 06/03/2024 at 07:05, 2 years 5 months ago Relief Therapeutics Announces Executive Changes Board Of Directors Executive Changes Biopharmaceutical Relief Therapeutics Senior Management
BRIEF published on 06/03/2024 at 07:05, 2 years 5 months ago Relief Therapeutics annonce des changements à la direction Conseil D'administration Biopharmaceutique Changements De Direction Thérapeutique De Soulagement La Haute Direction
PRESS RELEASE published on 06/03/2024 at 07:00, 2 years 5 months ago Relief Therapeutics Announces Executive Changes Relief Therapeutics announces executive changes as interim CEO Michelle Lock completes her mandate and transitions out, along with other key executives. Board to review management for optimal results Executive Changes Biopharmaceutical Relief Therapeutics Rare Diseases Management Review
BRIEF published on 05/30/2024 at 07:05, 2 years 5 months ago Relief Therapeutics annonce l'avis de convocation à l'assemblée générale annuelle des actionnaires Biopharmaceutique AGA 2024 Thérapeutique De Soulagement Rencontre D'actionnaires Genève
BRIEF published on 05/30/2024 at 07:05, 2 years 5 months ago Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders Biopharmaceutical Relief Therapeutics AGM 2024 Shareholders Meeting Geneva
Published on 11/13/2026 at 02:40, 3 hours 58 minutes ago Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 4 hours 28 minutes ago Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 7 hours 13 minutes ago Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 7 hours 33 minutes ago Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend
Published on 11/12/2026 at 23:00, 7 hours 38 minutes ago Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening
Published on 11/12/2026 at 23:10, 7 hours 28 minutes ago DeFi Technologies Inc. Announces Third Quarter 2026 Financial Results with Revenue of $18.3 Million, Operating Income of $7.0 Million, and Net Income of $22.3 Million
Published on 11/12/2026 at 22:35, 8 hours 3 minutes ago Silverfort Named a Leader in the IDC MarketScape for Worldwide Augmented Identity Security Solutions 2026 Vendor Assessment
Published on 11/12/2026 at 19:50, 10 hours 48 minutes ago Eurobattery Minerals receives shareholder requests for additional items on the agenda of the upcoming Extraordinary General Meeting
Published on 11/12/2026 at 18:25, 12 hours 13 minutes ago OMAN AWARDS TWO GREEN HYDROGEN PROJECTS IN DUQM AND LAUNCHES ROUND 4 GREEN-POWERED DATA CENTRE HYDROGEN AUCTION AT COP31
Published on 11/12/2026 at 18:14, 12 hours 24 minutes ago EQS-Adhoc: HUGO BOSS AG: Daniel Grieder to step down as CEO of HUGO BOSS effective December 31, 2026 - David Epstein appointed as CEO effective January 1, 2027
Published on 11/12/2026 at 23:12, 7 hours 25 minutes ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 7 hours 25 minutes ago Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 7 hours 38 minutes ago Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 12 hours 1 minute ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:36, 12 hours 1 minute ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/10/2026
